OTLC

Oncotelic Therapeutics, Inc.

Alert me on OTLC

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

After each filing

Oct 30 Buy Trieu Vuong Insider

1 week

−14.4%S&P −2.7%

1 month

Result in15 trading days

3 months

Result in57 trading days

6 months

Result in120 trading days

Jul 2 Buy Trieu Vuong Insider

1 week

−5.4%S&P +1.4%

1 month

−9.8%S&P +1.7%

3 months

−48.0%S&P +2.8%

6 months

Result in36 trading days

Jun 25 Buy Trieu Vuong Insider

1 week

−4.1%S&P +1.4%

1 month

−2.3%S&P +0.7%

3 months

−40.5%S&P +4.7%

6 months

Result in31 trading days

Jun 23 Buy Shah Amit B. Insider

1 week

−10.4%S&P +1.8%

1 month

−30.0%S&P +0.6%

3 months

−50.2%S&P +5.7%

6 months

Result in29 trading days

Jun 18 Buy Trieu Vuong Insider

1 week

−8.2%S&P −2.4%

1 month

−25.3%S&P +0.2%

3 months

−51.7%S&P +2.3%

6 months

Result in27 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for OTLC

13 held · newest 513 held · newest 2

Loading the filings.

See all 13 filings for OTLC

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.